Improvement of wasting by treatment with a humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody, MRA in multicentric Castleman's disease. A phase II clinical trial of 28 patients.

被引：0
|
作者：
Nishimoto, N [1 ]
Kanakura, Y [1 ]
Aozasa, K [1 ]
Johkoh, T [1 ]
Nakano, N [1 ]
Nakamura, M [1 ]
Ikeda, Y [1 ]
Sasaki, T [1 ]
Nishioka, K [1 ]
Hara, M [1 ]
Taguchi, H [1 ]
Kimura, Y [1 ]
Kato, Y [1 ]
Kishimoto, T [1 ]
Yoshizaki, K [1 ]
机构：
[1] Osaka Univ, Sch Hlth & Sport Sci, Dept Med Sci 1, Osaka, Japan
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
760
引用
下载
收藏
页码：202A / 203A
页数：2
相关论文
共 43 条
  • [1] A dose finding study of a humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody, MRA in multicentric Castleman's disease.
    Yoshizaki, K
    Kanakura, Y
    Aozasa, K
    Johkoh, T
    Nakamura, M
    Kodama, F
    Kumagai, S
    Asaoku, H
    Kishimoto, T
    Nishimoto, N
    BLOOD, 2002, 100 (11) : 363A - 363A
  • [2] Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
    Nishimoto, N
    Kanakura, Y
    Aozasa, K
    Johkoh, T
    Nakamura, M
    Nakano, S
    Nakano, N
    Ikeda, Y
    Sasaki, T
    Nishioka, K
    Hara, M
    Taguchi, H
    Kimura, Y
    Kato, Y
    Asaoku, H
    Kumagai, S
    Kodama, F
    Nakahara, H
    Hagihara, K
    Yoshizaki, K
    Kishimoto, T
    BLOOD, 2005, 106 (08) : 2627 - 2632
  • [3] Improvement In Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
    Nishimoto, N
    Sasai, M
    Shima, Y
    Nakagawa, M
    Matsumoto, T
    Shirai, T
    Kishimoto, T
    Yoshizaki, K
    BLOOD, 2000, 95 (01) : 56 - 61
  • [4] Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease
    Matsuyama, Masashi
    Suzuki, Takeshi
    Tsuboi, Hiroto
    Ito, Satoshi
    Mamura, Mizuko
    Goto, Daisuke
    Matsumoto, Isao
    Tsutsumi, Akito
    Sumida, Takayuki
    INTERNAL MEDICINE, 2007, 46 (11) : 771 - 774
  • [5] Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
    Tomioka, Yasuaki
    Otani, Shinji
    Tanaka, Shin
    Shien, Kazuhiko
    Suzawa, Ken
    Miyoshi, Kentaroh
    Yamamoto, Hiromasa
    Okazaki, Mikio
    Sugimoto, Seiichiro
    Yamane, Masaomi
    Toyooka, Shinichi
    SURGICAL CASE REPORTS, 2021, 7 (01)
  • [6] Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
    Yasuaki Tomioka
    Shinji Otani
    Shin Tanaka
    Kazuhiko Shien
    Ken Suzawa
    Kentaroh Miyoshi
    Hiromasa Yamamoto
    Mikio Okazaki
    Seiichiro Sugimoto
    Masaomi Yamane
    Shinichi Toyooka
    Surgical Case Reports, 7
  • [7] The long-term safety and efficacy of hunanized anti-interleukin-6 receptor monoclonal antibody, MRA in multicentri Castleman's disease.
    Nishimoto, N
    Kanakura, Y
    Aozasa, K
    Johkoh, T
    Nakamura, M
    Nakano, S
    Nakano, N
    Ikeda, Y
    Sasaki, T
    Nishioka, K
    Hara, M
    Taguchi, H
    Kimura, Y
    Kato, Y
    Asaoku, H
    Kodama, F
    Yoshizaki, K
    Kishimoto, T
    BLOOD, 2003, 102 (11) : 646A - 647A
  • [8] BLOCKING INTERLEUKIN-6 (IL-6) BY AN ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) MONOCLONAL ANTIBODY IN RHEUMATOID ARTHRITIS (RA)
    Choy, E. H. S.
    Isenberg, D. A.
    Garrood, T.
    Farrow, S.
    Ioannou, Y.
    Bird, H.
    Cheung, N.
    Williams, B. D.
    Hazleman, B.
    Price, R.
    Kishimoto, T.
    Panayi, G. S.
    RHEUMATOLOGY, 2002, 41 : 15 - 15
  • [9] Therapeutic efficacy of humanized anti-interleukin-6 receptor monoclonal antibody in renal involvement complicating Castleman's disease
    Kanai, Hidetoshi
    Hirano, Tadashi
    Arimura, Yosihide
    Yokota, Tadaaki
    Masutani, Kosuke
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 290 - 290
  • [10] A Case of Multicentric Castleman's Disease Having Lung Lesion Successfully Treated with Humanized Anti-interleukin-6 Receptor Antibody, Tocilizumab
    Higuchi, Tomoaki
    Nakanishi, Takashi
    Takada, Kunio
    Matsumoto, Mitsuyo
    Okada, Makoto
    Horikoshi, Hideyuki
    Suzuki, Kimihiro
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (09) : 1364 - 1367
12345